Abstract:Periodontal diseases are chronic infectious diseases and are a major oral health burden. With the progress in the understanding of etiology, epidemiology and pathogenesis of periodontal diseases coupled with the understanding of the polymicrobial synergy in the dysbiotic oral microbial flora, several new therapeutic targets have been identified. The strategies to curb bacterial growth and production of factors that gradually destroy the tissue surrounding and supporting the teeth have been the cornerstone for inhibiting periodontitis. Systemic administration of antibiotics for the treatment of periodontitis have shown several drawbacks including: inadequate antibiotic concentration at the site of the periodontal pocket, a rapid decline of the plasma antibiotic concentration to sub-therapeutic levels, the development of microbial resistance due to sub-therapeutic drug levels and peak-plasma antibiotic concentrations which may be associated with various side effects. These obvious disadvantages have evoked an interest in the development of localized drug delivery systems that can provide an effective concentration of antibiotic at the periodontal site for the duration of the treatment with minimal side effects. A targeted sustained release device which could be inserted in the periodontal pocket and prolong the therapeutic levels at the site of action at a much lower dose is the need of the hour. Chitosan, a deacetylated derivative of chitin has attracted considerable attention owing to its special properties including antimicrobial efficacy, biodegradability, biocompatibility and non-toxicity. It also has the propensity to act as hydrating agent and display tissue healing and osteoinducting effect. The aim of this review is to shine a spotlight on the chitosan based devices developed for drug delivery application in the effective treatment of various periodontal disorders. The chitosan based carriers like fibers, films, sponge, microparticles, nanoparticles, gels that have been designed for sustained release of drug into the periodontal pocket are highlighted.

Controlled drug release in periodontics: a review of new therapies

Electronically Powered Drug Delivery Devices: Considerations and Challenges

Periodontal Gel For The Targeted Drug Delivery In The Periodontal Cavity For Management Of Periodontitis And Gingivitis

Principles and Clinical Applications of Periodontal Controlled Drug Delivery with Tetracycline Fibers.

Local Delivery and Controlled Release Drugs Systems: A New Approach for the Clinical Treatment of Periodontitis Therapy

Local drug delivery systems as therapeutic strategies against periodontitis: A systematic review

Dental Drug Delivery System used in Periodontitis

Polysaccharide-Based Drug Delivery Systems for the Treatment of Periodontitis

Gradual Drug Release Membranes and Films Used for the Treatment of Periodontal Disease

In situ gel drug delivery system for periodontitis: an insight review

The role of controlled drug delivery for periodontitis. The Research, Science and Therapy Committee of the American Academy of Periodontology.

Potential of chitosan-based carrier for periodontal drug delivery

A tunable and injectable local drug delivery system for personalized periodontal application

In-situ forming implants for the treatment of periodontal diseases: Simultaneous controlled release of an antiseptic and an anti-inflammatory drug

Controlled Drug Release for Tissue Engineering.

Nano-Based Drug Delivery Systems for Periodontal Tissue Regeneration

Enhancing periodontal defences with nanofiber treatment: recent advances and future prospects

Novel biopolymer spray formulation for drug delivery in precision dentistry

Controlled dual drug release from adhesive electrospun patches for prevention and treatment of alveolar osteitis

Impact of local drug delivery and natural agents as new target strategies against periodontitis: new challenges for personalized therapeutic approach

Strategies to develop polymeric microneedles for controlled drug release